semaglutide select Beyond obesity: Novo's re-defines cardiovascular risk management Full SELECT Results Affirm CV

As the first triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors, it offers a unique mechanism of action with complementary effects on multiple aspects of metabolism

To ensure the best results, treatment plans should be tailored to the specific needs of individual patients, considering their ethnic backgrounds and socio-economic conditions, among other factors

Stay updated on the Ozempic stomach paralysis lawsuit, covering allegations, lawsuit status, drug details, and legal strategies for those affected.

Explore how Ozempic helps manage type 2 diabetes in Australia

mL = milliliter

**GLP Therapies Are Not Weight-Loss Drugs. They Are Rewriting Metabolic Medicine.** Pause for a second